SCHEMBL19485809

SCHEMBL19485809

CC(C)Cc1ccc2cc3c(cc2c1)Nc1ccccc1N3

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
SIGMAR1 Q99720 3/20 0.41
ABL1 P00519 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2A6 P11509 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
BCHE P06276 1/20 0.37
ADRB2 P07550 2/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
NOX1 Q9Y5S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19485771 0.92 HTR2A (0.42) HTR2AHTR2CHTR2BSIGMAR1ABL1
SCHEMBL22536330 0.92 HTR2A (0.42) HTR2AHTR2CHTR2BSIGMAR1ABL1
SCHEMBL11405537 0.82 HTR2A (0.63) HTR2AHTR2CHTR2BSIGMAR1CYP1A2
SCHEMBL24806246 0.80 GABRA1 (0.47) HTR2AHTR2BCYP1A2GABRA1GABRB2
SCHEMBL20008485 0.80 GABRA1 (0.47) HTR2AHTR2BCYP1A2GABRA1GABRB2
SCHEMBL3677922 0.80 HTR2A (0.71) HTR2AHTR2CHTR2BSIGMAR1CYP1A2
SCHEMBL28292686 0.80 HTR2A (0.57) HTR2AHTR2CHTR2BSIGMAR1ABL1
SCHEMBL30127774 0.71 NOX1 (0.58) HTR2CCYP1A2CYP2A6BCHENPC1
SCHEMBL10706836 0.71 NOX1 (0.58) HTR2CCYP1A2CYP2A6BCHENPC1
SCHEMBL24819489 0.71 HTR2A (0.48) HTR2AHTR2CHTR2BSIGMAR1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796754-B2 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives AMBRX, INC. (US) 2017-10-24 US disclosed